Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Thomas J. Kipps, Herbert Eradat, Sebastian Grosicki, John Catalano, Walter Cosolo, Iryna S. Dyagil, Sreeni Yalamanchili, Akiko Chai, Srikumar Sahasranaman, Elizabeth Punnoose, Deborah Hurst & Halyna Pylypenko. (2015) A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 56:10, pages 2826-2833.
Read now
Read now
Articles from other publishers (2)
Alok K. Mishra. 2023. Phagocytosis - Main Key of Immune System. Phagocytosis - Main Key of Immune System.
Ayşegül Dalmızrak, Nur Selvi Günel, Burçin Tezcanlı Kaymaz, Fahri Şahin, Güray Saydam & Buket Kosova. (2019) Effects of Rituximab on JAK-STAT and NF-κB signaling pathways in acute lymphoblastic leukemia and chronic lymphocytic leukemia. Turkish Journal of Biochemistry 44:4, pages 499-509.
Crossref
Crossref